Amydis Diagnostics

San Diego, United States Founded: 2013 • Age: 13 yrs
Developer of diagnostics test for detection of Alzheimers disease

About Amydis Diagnostics

Amydis Diagnostics is a company based in San Diego (United States) founded in 2013.. Amydis Diagnostics has raised $5.69 million across 13 funding rounds from investors including NIH, HHS and National Institute on Aging. Amydis Diagnostics offers products and services including Ocular Tracers. Amydis Diagnostics operates in a competitive market with competitors including C₂N Diagnostics, Todos Medical, ADmit Therapeutics, ALZpath and SYNAPS Dx, among others.

  • Headquarter San Diego, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $5.69 M (USD)

    in 13 rounds

  • Latest Funding Round
  • Investors
    NIH

    & 2 more

  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Amydis Diagnostics

Amydis Diagnostics offers a comprehensive portfolio of products and services, including Ocular Tracers. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Tracers for detecting molecular biomarkers in diseases via ocular imaging.

People of Amydis Diagnostics
Headcount 10-50
Employee Profiles 9
Board Members and Advisors 16
Employee Profiles
People
Svasti Sharma
Assistant Research Scientist
People
Stella Sarraf
CEO
People
Jack Thrift
CFO
People
Kerri Nelson
Chief Operating Officer

Unlock access to complete

Board Members and Advisors
people
Alfredo Sadun
Advisor
people
David S. Boyer
Advisor
people
SriniVas R. Sadda
Advisor
people
Steven D. Schwartz
Advisor

Unlock access to complete

Funding Insights of Amydis Diagnostics

Amydis Diagnostics has successfully raised a total of $5.69M across 13 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 13
  • Last Round
  • First Round
  • Investors Count 3
Date Amount Transaction Name Valuation Lead Investors Investors
Aug, 2022 Amount Grant - Amydis Diagnostics Valuation

investors

NIH
Aug, 2022 Amount Grant - Amydis Diagnostics Valuation

investors

HHS
Apr, 2022 Amount Series A - Amydis Diagnostics Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Amydis Diagnostics

Amydis Diagnostics has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include NIH, HHS and National Institute on Aging. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Public health and human services are overseen by HHS.
Founded Year Domain Location
Research and information on aging are provided by this institute.
Founded Year Domain Location
Drug discovery services are provided to the biopharma sector.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Amydis Diagnostics

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Amydis Diagnostics

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Amydis Diagnostics Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Amydis Diagnostics

Amydis Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as C₂N Diagnostics, Todos Medical, ADmit Therapeutics, ALZpath and SYNAPS Dx, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Diagnostics and therapies for Alzheimer's disease are developed.
domain founded_year HQ Location
Todos Medical is focused on developing diagnostic blood tests.
domain founded_year HQ Location
Early Alzheimer's detection is facilitated through blood-based epigenetic diagnostics.
domain founded_year HQ Location
Diagnostic solutions for Alzheimer's disease are developed using blood-based biomarkers.
domain founded_year HQ Location
Developer of a diagnostic test to detect Alzheimer's disease
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Amydis Diagnostics

Frequently Asked Questions about Amydis Diagnostics

When was Amydis Diagnostics founded?

Amydis Diagnostics was founded in 2013 and raised its 1st funding round 2 years after it was founded.

Where is Amydis Diagnostics located?

Amydis Diagnostics is headquartered in San Diego, United States. It is registered at San Diego, California, United States.

Is Amydis Diagnostics a funded company?

Amydis Diagnostics is a funded company, having raised a total of $5.69M across 13 funding rounds to date. The company's 1st funding round was a Series A of $5.69M, raised on Sep 29, 2015.

What does Amydis Diagnostics do?

Developer of diagnostics test for detection of Alzheimers disease. The company is developing a novel family of fluorescent probes to be used as diagnostic agents to image neurodegenerative diseases through an ophthalmic approach using standard technology available in eye care specialist offices.

Who are the top competitors of Amydis Diagnostics?

Amydis Diagnostics's top competitors include ADmit Therapeutics, C₂N Diagnostics and Todos Medical.

What products or services does Amydis Diagnostics offer?

Amydis Diagnostics offers Ocular Tracers.

Who are Amydis Diagnostics's investors?

Amydis Diagnostics has 3 investors. Key investors include NIH, HHS, and National Institute on Aging.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available